Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

580 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-27

Study Completion Date

2021-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Laparoscopic sentinel lymph node biopsy and stomach preserving surgery in early gastric cancer is less invasive method which can increase quality of life. For last two years, multicenter quality control study (Phase II) has been performed in Korea and tolerable results were observed. Based on these results, multicenter phase III trial is required to validate the clinical role of laparoscopic sentinel lymph node biopsy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer

NCT01544413

Early Gastric Cancer

COMPLETED NA

Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer

NCT01088204

Gastric Cancer

UNKNOWN PHASE2

Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer

NCT06788548

Early Gastric Cancer

RECRUITING NA

Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection

NCT02572050

Gastric Cancer

UNKNOWN PHASE2

Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer

NCT03273920

Gastric Cancer

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The final analyses include the modified intention to treatment analysis (full analysis set) and Per Protocol analysis (including patients who underwent assigned surgery without agreement withdrawal).

1. Injection of tracer and sentinel basin dissection

* Tracer: Tc 99m HSA (Human serum albumin, 2ml, 0.1mCi/ml) + ICG (indocyanine green, 2ml, 5mg/ml)
* Endoscopic injection of tracer on 4 sites around gastric cancer
* Identification of sentinel basin using laparoscopic probe (Neoprobe)
* Laparoscopic sentinel basin dissection and identification of sentinel node at back table
2. Surgical considerations

* If positive sentinel nodes were diagnosed in frozen section, conventional gastrectomy is performed.
* If micrometastasis or isolate tumor cells in sentinel basin lymph nodes were diagnosed in the permanent pathology, re-operation of conventional gastrectomy is not performed.
* However, re-operation of converntional gastrectomy should be performed in case of macrometastasis, deep and lateral margin positive, more than pT2 lesion in the permanent pathology.
3. H.pylori eradication - There was no clear evidence that H.pylori eradication reduced development of metachronous gastric cancer. H.pylori eradication was planned to perform according to physician's decision or patient's need. However, recently, the effect of H.pylori eradication in development of metachronous gastric cancer was published in NEJM (Choi et al. 2018). Therefore, from now on, H. pylori eradication will be recommended to enrolled patients with H.pylori.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Stomach preserving surgery after laparoscopic sentinel node dissection and evaluation

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laparoscopic Sentinel Node Biopsy

Laparoscopic Sentinel Node Biopsy or Stomach Preserving Surgery could be performed in this arm

Group Type EXPERIMENTAL

Laparoscopic Sentinel Node Biopsy

Intervention Type PROCEDURE

Laparoscopic Sentinel Node Biopsy or Stomach Preserving Surgery could be performed in the experimental arm.

Laparoscopy Assisted Gastrectomy

Conventional procedure is laparoscopy assisted gastrectomy in early gastric cancer patient.

Group Type ACTIVE_COMPARATOR

Laparoscopy Assisted Gastrectomy

Intervention Type PROCEDURE

In the control arm, laparoscopy assisted gastrectomy with lymph node dissection (D1+ or more) will be performed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic Sentinel Node Biopsy

Laparoscopic Sentinel Node Biopsy or Stomach Preserving Surgery could be performed in the experimental arm.

Intervention Type PROCEDURE

Laparoscopy Assisted Gastrectomy

In the control arm, laparoscopy assisted gastrectomy with lymph node dissection (D1+ or more) will be performed.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* single lesion of adenocarcinoma in preoperative endoscopic biopsy
* clinical stage T1N0 in the preoperative evaluation of endoscopy and computed tomography
* tumor size: less than 3cm
* location: 2cm far from the pylorus or cardia
* aged 20 to 80
* ECOG 0 or 1
* patient who signed the agreement
* patient who is suspected to underwent laparoscopy assisted gastrectomy

Exclusion Criteria

* indication of endoscopic submucosal resection
* inoperable due to poor cardiac, pulmonary function
* pregnant
* having allergic reaction, previous upper abdominal surgery except laparoscopic cholecystectomy, previous radiation therapy to upper abdomen
* diagnosed as malignancy within 5 years except carcinoma in situ of cervix cancer and thyroid cancer

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No